Proteomics involves the study of proteomes which are the entire set of proteins produced or modified by an organism, system or biological context. Proteomics provide several advantages over genomics as it helps to better understand biological functions and dynamic changes that occur at the protein level in cells, tissues or body fluids. Proteomic technologies are increasingly being adopted in drug discovery and development process to generate comprehensive protein expression profiles from different diseases. It also aids in identifying novel biomarkers and drug targets. Adoption of proteomics in personalized medicine enables tailored treatment based on an individual's proteomic profile.
The global Proteomics Market is estimated to be valued at US$ 36.8 Bn in 2023 and is expected to exhibit a CAGR of 19% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Adoption of proteomics in drug discovery and personalized medicine is one of the major trends fueling growth of the proteomics market. Proteomic technologies helps in better understanding of disease mechanisms and biological pathways. This aids researcher in identifying novel drug targets and biomarkers. For instance, it is being widely used in cancer research to understand cancer at protein level and identify personalized targets for treatment. Growing applications of proteomics in precision medicine is expected to drive significant market growth over the forecast period.
Segment Analysis
The global proteomics market is dominated by the drug discovery segment. Next generation protein sequencing and fragmentation techniques allow researchers to identify disease biomarkers and potential drug targets. Mass spectrometry proteomics has enabled high-throughput screening to identify protein-ligand interactions critical for drug efficacy and safety assessments.
Key Takeaways
The global Proteomics Market Share is expected to witness high growth over the forecast period of 2023 to 2030 supported by increasing government funding for proteomics research and growing applications in precision medicine.
Regional analysis: North America currently accounts for the largest share of the proteomics market owing to the strong presence of leading pharmaceutical companies and research organizations. The region is anticipated tocontinue its dominance led by the United States due to increasing research on proteome analysis for chronic disease diagnostics and therapeutics. Asia Pacific is poised to be the fastest growing regional market supported by rising R&D expenditure, improving healthcare infrastructure and growing collaboration between academia and industry in countries such as China and India.
Key players operating in the proteomics market are Super Vac, Ziamatic Corp., Akron Brass Company, Fire Hooks Unlimited, Inc., Tempest Technology Corporation, CMC Rescue, Inc., SavaTech Corp., Water Rescue Innovations, RUTH LEE Ltd., Mustang Survival, DURATEK Inc., Safety & Rescue Australia, WernerCo, Sterling Rope Company, Inc., PETZL Distribution. Thermo Fisher Scientific currently dominates the market with the widest proteomics product portfolio comprising mass spectrometers, sample preparation kits and bioinformatics software. Other major players include Danaher Corporation, Merck KGaA, Agilent Technologies and Bruker Corporation.
For more insights, read- https://www.newsanalyticspro.com/proteomics-market-trends-size-and-share-analysis/
For more details on the report, Read- https://careersplay.com/the-rising-trend-of-biohacking-and-its-opportunities
Comments
0 comment